Related Experiment Video
Updated: Jul 20, 2026
Endoscopic Bilateral Nipple-sparing Mastectomy via a Single Axillary Incision with Immediate Pre-pectoral Implant-based Breast Reconstruction
Published on: May 17, 2024
Secretory breast cancer in a 7.5-year old boy
J Szántó1, C András, J Tsakiris
1Department of Medical Oncology, Medical and Health Science Centre, University of Debrecen, Nagyerdei Krt 98, Debrecen 4012, Hungary. szantoj@axelero.hu
Insights
Pediatric breast cancer is rare, leading to varied treatment approaches. This case study details a 7.5-year-old boy
Area of Science:
- Oncology
- Pediatric Oncology
- Surgical Oncology
Background:
- Breast cancer in children is exceptionally rare, lacking established treatment guidelines.
- Optimal management strategies for pediatric breast cancer remain under investigation.
Observation:
- A case report of a 7.5-year-old male diagnosed with breast cancer.
- The patient underwent radical mastectomy with sentinel lymph node biopsy.
Findings:
- No malignant cells were found in the sentinel node.
- Genetic testing revealed no BRCA1-2 mutations.
- The patient did not receive adjuvant radio- or chemotherapy, adopting a 'wait-and-see' approach.
Implications:
- This case highlights a conservative management strategy for pediatric breast cancer.
- The 'wait-and-see' approach may be viable in select pediatric cases without lymph node or genetic predisposition.
- Further observation is necessary to determine long-term outcomes and the need for subsequent treatments.
Abstract:
Breast cancer is extremely rare in children, and consequently no consensus has been reached on the optimal treatment modalities. The medical history and treatment plan for a 7.5-year old male breast cancer patient is described. Radical mastectomy with sentinel node biopsy was performed in October 2002. As no malignant cells were detected in the sentinel node, and no BRCA1-2 mutations were detected, no further radio- or chemotherapy was performed. A "wait-and-see" policy was decided on. Further treatment will be given if this becomes necessary with the development of metastases.
